UPDATE: JPMorgan Downgrades Orchard Therapeutics (ORTX) to Underweight on Lack of Meaningful Short-term Catalysts and Negative Sentiment

Go back to UPDATE: JPMorgan Downgrades Orchard Therapeutics (ORTX) to Underweight on Lack of Meaningful Short-term Catalysts and Negative Sentiment
(NASDAQ: ORTX) Delayed: 16.70 --0 (-0%)
Previous Close $16.70    52 Week High
Open $67.14    52 Week Low
Day High $16.70    P/E N/A 
Day Low $16.70    EPS
Volume 380,258